Fluvastatin is an HMGCR (HMG-CoA reductase) inhibitor. The compound is described to inhibit cell proliferation, illicit apoptosis, and protect against oxidative stress. Human hepatocellular carcinoma cell (HCC) studies indicate that Fluvastatin induces G2/M phase arrest. In the presence of Fluvastatin, HCC cells show a decrease of Bcl-2 and procaspase-9 expression, and an increase in Bax, cleaved caspase-3, and cytochrome c.
API's & Drug Standards
|Formula||C24H25FNO4 · Na · xH2O|
Send us your enquiry for Fluvastatin. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Fluvastatin email us and we will include your contribution on the website.